Angewandte Chemie International Edition,
Journal Year:
2024,
Volume and Issue:
63(31)
Published: May 21, 2024
Abstract
An
optimal
cancer
chemotherapy
regimen
should
effectively
address
the
drug
resistance
of
tumors
while
eliciting
antitumor‐immune
responses.
Research
has
shown
that
non‐apoptotic
cell
death,
such
as
pyroptosis
and
ferroptosis,
can
enhance
immune
response.
Despite
this,
there
been
limited
investigation
reporting
on
mechanisms
oncosis
its
correlation
with
Herein,
we
designed
synthesized
a
Ru(II)
complex
targeted
nucleus
mitochondria
to
induce
oncosis.
Briefly,
disrupts
DNA,
which
active
polyADP‐ribose
polymerase
1,
accompanied
by
ATP
consumption
porimin
activation.
Concurrently,
mitochondrial
damage
endoplasmic
reticulum
stress
result
in
release
Ca
2+
ions
increased
expression
Calpain
1.
Subsequently,
specific
pore
proteins
1
promote
cristae
destruction
or
vacuolation,
ultimately
leading
membrane
rupture.
The
analysis
RNA
sequencing
demonstrates
initiate
oncosis‐associated
pathway
activate
both
innate
adaptive
immunity.
In
vivo
experiments
have
confirmed
promotes
dendritic
maturation
awakens
cytotoxic
T
lymphocytes
but
also
activates
inducing
polarization
macrophages
towards
an
M1
phenotype.
Chemical Science,
Journal Year:
2024,
Volume and Issue:
15(27), P. 10477 - 10490
Published: Jan. 1, 2024
Ferroptosis
has
emerged
as
a
form
of
programmed
cell
death
and
exhibits
remarkable
promise
for
anticancer
therapy.
However,
it
is
challenging
to
discover
ferroptosis
inducers
with
new
chemotypes
high
ferroptosis-inducing
potency.
Herein,
we
report
series
ferrocenyl-appended
GPX4
inhibitors
rationally
designed
in
"one
stone
kills
two
birds"
strategy.
selectivity
assays,
inhibitory
activity
CETSA
experiments
validated
the
inhibition
novel
compounds
on
GPX4.
In
particular,
ROS-related
bioactivity
assays
highlighted
ROS-inducing
ability
17
at
molecular
level
their
enhancement
cellular
level.
These
data
confirmed
dual
role
ferrocene
both
bioisostere
motif
maintaining
capacity
certain
molecules
also
ROS
producer
enhance
vulnerability
cancer
cells,
thereby
attenuating
tumor
growth
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 14, 2025
Abstract
The
tumor
microenvironment
(TME)
severely
limits
the
efficacy
of
clinical
applications
photodynamic
therapy
(PDT).
development
a
functional
agent
allowing
full
use
TME
to
boost
synergistic
PDT
and
ferroptosis
anti‐tumor
efficiency
is
an
appealing
yet
significantly
challenging
task.
Herein,
overcome
adverse
influence
on
hypoxia
high
level
glutathione
(GSH)
in
TME,
imine
bond
introduced
into
Ir(III)‐ferrocene
complex
construct
small
molecule
drug,
named
Ir‐Fc,
for
tumors’
imaging
therapy.
cleavage
lysosome
effectively
disrupts
photoinduced
electron
transfer
(PET)
process,
realizing
decomposition
Ir‐Fc
Fc‐CHO
Ir‐NH
2
.
produces
•OH
by
Fenton
reactions
under
dark
conditions
induces
cells,
shows
prominent
performance
type‐I
type‐II
reactive
oxygen
species
(ROS)
production.
Meanwhile,
pathway
simultaneously
consumes
large
amounts
GSH
O
relieving
hypoxia.
These
distinctive
outputs
make
exceptional
effective
This
study
thus
brings
new
revolutionary
protocol
practical
cancer
treatment.
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 7, 2025
Nanozymes
offer
diverse
therapeutic
potentials
for
cancer
treatment
which
is
dependent
on
the
development
of
nanomaterials.
Quasi-metal-organic
framework
a
class
metal-organic
framework-derived
nanomaterials
with
transition
state
from
frameworks
towards
metal
oxide
featuring
porous
structure
and
high
activity.
Herein
an
iron-based
quasi-metal-organic
nanozyme
Q-MIL-53(Fe)
reported
via
controlled
deligandation
strategy,
exhibiting
enhanced
peroxidase-/catalase-mimic
activity
glutathione
depletion
capacity,
whose
underlying
mechanisms
are
studied
density
functional
theory
calculations.
demonstrates
biocompatibility
superior
antitumor
efficacy
compared
to
pristine
MIL-53(Fe).
It
can
activate
immune
response
by
inducing
ferroptosis
immunogenic
cell
death,
promoting
dendritic
maturation
T
lymphocytes
infiltration.
Furthermore,
combination
programmed
death
protein
1
antibody
amplifies
immunotherapy.
This
study
validates
its
immunotherapy
induction
potential.
would
broaden
application
open
avenues
developing
nanozymes.
treatment.
In
this
work,
authors
report
quasi-metal
organic
peroxidase
catalase-mimicking
capacity
use
it
tumor
death.
Phytotherapy Research,
Journal Year:
2024,
Volume and Issue:
38(3), P. 1623 - 1650
Published: Feb. 1, 2024
Abstract
Hepatocellular
carcinoma
(HCC),
presently
the
second
leading
cause
of
global
cancer‐related
mortality,
continues
to
pose
significant
challenges
in
realm
medical
oncology,
impacting
both
clinical
drug
selection
and
mechanistic
research.
Recent
investigations
have
unveiled
autophagy‐related
signaling
as
a
promising
avenue
for
HCC
treatment.
A
growing
body
research
has
highlighted
pivotal
role
autophagy‐modulating
natural
products
inhibiting
progression.
In
this
context,
we
provide
concise
overview
fundamental
autophagy
mechanism
delineate
involvement
autophagic
pathways
development.
Additionally,
review
pertinent
studies
demonstrating
how
regulate
mitigate
HCC.
Our
findings
indicate
that
exhibit
cytotoxic
effects
through
induction
excessive
autophagy,
simultaneously
impeding
cell
proliferation
by
inhibition,
thereby
depriving
cells
essential
energy.
These
been
associated
with
various
pathways,
including
PI3K/AKT,
MAPK,
AMPK,
Wnt/β‐catenin,
Beclin‐1,
ferroautophagy.
results
underscore
considerable
therapeutic
potential
However,
it
is
important
note
present
study
did
not
establish
definitive
thresholds
or
inhibition
products.
Further
domain
imperative
gain
comprehensive
insights
into
dual
equipping
us
better
understanding
double‐edged
sword
management.
Angewandte Chemie International Edition,
Journal Year:
2024,
Volume and Issue:
63(48)
Published: Aug. 13, 2024
Abstract
Despite
significant
improvements
in
the
treatment
of
cancerous
tumors
last
decades,
cancer
remains
one
deadliest
diseases
worldwide.
To
overcome
shortcomings
currently
applied
chemotherapeutic
treatments,
much
research
efforts
have
been
devoted
towards
development
ferroptosis
inducing
anticancer
agents.
Ferroptosis
is
a
newly
described
form
regulated,
non‐apoptotic
cell
death
that
associated
with
high
potential
inside
clinics.
Herein,
chemical
synthesis
and
biological
evaluation
Co(III)
polypyridine
sulfasalazine
complex
as
inducer
reported.
Upon
entering
cells,
metal
primarily
accumulated
mitochondria,
triggering
production
hydroxy
radicals
lipid
peroxides,
ultimately
causing
by
ferroptosis.
The
compound
demonstrated
to
eradicate
various
monolayer
cells
well
colon
carcinoma
multicellular
tumor
spheroids.
best
our
knowledge
this
study
reports
on
first
example
capable
Angewandte Chemie International Edition,
Journal Year:
2024,
Volume and Issue:
63(49)
Published: Aug. 24, 2024
Abstract
The
integration
of
pyroptosis
and
ferroptosis
hybrid
cell
death
induction
to
augment
immune
activation
represents
a
promising
avenue
for
anti‐tumor
treatment,
but
there
is
lack
research.
Herein,
we
developed
two
iridium
(III)‐triphenylamine
photosensitizers,
IrC
IrF
,
with
the
capacity
disrupt
redox
balance
induce
photo‐driven
cascade
damage
DNA
Kelch‐like
ECH‐associated
protein
1
(KEAP1).
absent
in
melanoma
2
(AIM2)‐related
cytoplasmic
nucleic
acid‐sensing
pathway,
triggered
by
damaged
DNA,
leads
gasdermin
D
(GSDMD)‐mediated
pyroptosis.
Simultaneously,
iron
homeostasis,
regulated
KEAP1/nuclear
factor
erythroid
2‐related
(NRF2)/heme
oxygenase
(HO‐1)
serves
as
pivotal
bridge,
facilitating
not
only
E
(GSDME)‐mediated
non‐canonical
pyroptosis,
also
synergy
glutathione
peroxidase
4
(GPX4)
depletion.
collaborative
action
generates
synergistic
effect
that
elicits
immunogenic
death,
stimulates
robust
response
effectively
inhibits
tumor
growth
vivo.
Our
work
introduces
first
metal‐based
small
molecule
dual‐inducers
potent
cancer
immunotherapy,
highlights
significance
homeostasis
vital
hub
connecting
effects
ferroptosis.
ChemPlusChem,
Journal Year:
2024,
Volume and Issue:
89(6)
Published: Feb. 7, 2024
Metal
ions
such
as
iron,
zinc,
copper,
manganese,
and
calcium
are
essential
for
normal
cellular
processes,
including
DNA
synthesis,
enzyme
activity,
signaling,
oxidative
stress
regulation.
When
the
balance
of
metal
homeostasis
is
disrupted,
it
can
lead
to
various
pathological
conditions,
cancer.
Thus,
understanding
role
in
cancer
has
led
development
anti-tumor
strategies
that
specifically
target
imbalance.
Up
now,
diverse
small
molecule-based
chelators,
ionophores,
complexes,
metal-based
nanomaterials
have
been
developed
restore
metals
or
exploit
dysregulation
therapeutic
purposes.
They
hold
great
promise
inhibiting
tumor
growth,
preventing
metastasis,
enhancing
effectiveness
existing
therapies.
In
this
review,
we
aim
provide
a
comprehensive
summary
employed
modulate
therapy.
Their
modulation
mechanisms
succinctly
described,
their
recent
applications
field
therapy
discussed.
At
end,
limitations
these
approaches
addressed,
potential
avenues
future
developments
explored.
ChemMedChem,
Journal Year:
2024,
Volume and Issue:
19(15)
Published: May 2, 2024
Abstract
Mitochondria,
recognized
as
the
cellular
powerhouses,
are
indispensable
organelles
responsible
for
crucial
processes,
such
energy
metabolism,
material
synthesis,
and
signaling
transduction.
Their
intricate
involvement
in
a
broad
spectrum
of
diseases,
particularly
cancer,
has
propelled
exploration
mitochondria‐targeting
treatment
promising
strategy
cancer
therapy.
Since
groundbreaking
discovery
cisplatin,
trajectory
research
on
development
metal
complexes
have
been
marked
by
continuous
advancement,
giving
rise
to
diverse
array
metallodrugs
characterized
variations
ligand
types,
center
properties,
oxidation
states.
By
specifically
targeting
mitochondria,
these
exhibit
remarkable
ability
elicit
various
programmed
cell
death
pathways,
encompassing
apoptosis,
autophagy,
ferroptosis.
This
review
primarily
focuses
recent
developments
transition
metal‐based
agents,
offering
comprehensive
their
capacity
induce
distinct
modes.
The
aim
is
not
only
disseminate
knowledge
but
also
stimulate
an
active
field
toward
new
clinical
applications
novel
anticancer
mechanisms.